FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancer
Robert Stoehr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ellen C. Zwarthoff(Erasmus MC), Simone Bertz(Taipei Institute of Pathology), C. Adam(Ludwig-Maximilians-Universität München), Ruth Knuechel(RWTH Aachen University), Johanna van Oers(Albert Einstein College of Medicine), Dirk Zaak
Cancer Research
April 15, 2006
Cited by 3
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381